Page last updated: 2024-08-21

isoxazoles and Cardiac Hypertrophy

isoxazoles has been researched along with Cardiac Hypertrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frangogiannis, NG; Fujikura, K; Garcia, MJ; Palanski, BA; Shinde, AV; Su, Y1
Block, N; Brock, TA; Chen, SJ; Chen, YF; Dixon, RA; Munsch, CL; Sherwood, SJ; Tilton, RG; Wu, C1

Other Studies

2 other study(ies) available for isoxazoles and Cardiac Hypertrophy

ArticleYear
Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.
    Journal of molecular and cellular cardiology, 2018, Volume: 117

    Topics: Animals; Cardiomegaly; Collagen; Diastole; Extracellular Matrix; Female; Fibroblasts; Fibrosis; GTP-Binding Proteins; Hypertrophy, Left Ventricular; Isoxazoles; Male; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Pressure; Protein Glutamine gamma Glutamyltransferase 2; Pyrrolidines; Quinolines; Recombinant Proteins; Stroke Volume; Tissue Inhibitor of Metalloproteinases; Transcription, Genetic; Transglutaminases; Up-Regulation; Ventricular Remodeling

2018
Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
    Pulmonary pharmacology & therapeutics, 2000, Volume: 13, Issue:2

    Topics: Animals; Cardiomegaly; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypertrophy; Hypoxia; Isoxazoles; Male; Monocrotaline; Oxygen; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Thiophenes; Vasoconstriction; Weight Gain

2000